According to previous reports, during early or late diabetic nephropathy, glomerular podocytes can secrete CXCL12, and inhibition of CXCL12 can significantly reduce glomerulosclerosis and proteinuria in patients with type 2 diabetes [31]. This evidence concerns the gene CXCL12 and glomerulosclerosis.